Business● Low20m ago · Nov 10, 2026, 12:05 PM
Humacyte GAAP EPS of -$0.06 beats by $0.03, revenue of $1.03M beats by $0.26M
GlobeAlert Desk · curated from Seeking Alpha Tech · global
Humacyte reported GAAP EPS of -$0.06, exceeding estimates by $0.03, and revenue of $1.03M, surpassing estimates by $0.26M. This indicates a better financial performance than projected.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business19m agoOvid Therapeutics GAAP EPS of -$0.10 misses by $0.02Seeking Alpha TechBusiness19m agoTransDigm Group slips as profit outlook falls short of estimatesSeeking Alpha TechBusiness21m agoOpus Genetics GAAP EPS of -$0.46 misses by $0.31, revenue of $1.14M misses by $0.94MSeeking Alpha TechBusiness21m agoPalladyne beats top-line and bottom-line estimates; raises FY26 outlookSeeking Alpha Tech